Continuity of Medication Use by US Adults With Diabetes, 2005-2019

Puneet Kaur Chehal(Emory University), Mohammed K. Ali(Emory University), Sara Turbow(Emory University), J. Sonya Haw(Emory University), Tegveer S. Uppal(Emory University), Gail Fernandes(Merck & Co., Inc., Rahway, NJ, USA (United States)), Swapnil Rajpathak(Albert Einstein College of Medicine), K.M. Venkat Narayan(Emory University), Megha Shah(Emory University)
JAMA Network Open
January 30, 2023
10.1001/jamanetworkopen.2022.53562
Cited by 13

Related Papers

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|9k
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|8.4k
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
|The Lancet|2011|3.6k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
|The Lancet|2015|2.8k